Brind.

NIH funded a leading study involving investigators from Massachusetts General Hospital and company Quantum BioPharma.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

National Institutes of Health Massachusetts General Hospital QUANTUM

Keep exploring

The entities involved

National Institutes of Health
government organization in Shah Alam, Malaysia
- PDS Biotechnology and the National Cancer Institute entered into a collaborative R&D agreement.Sun 13:48
- The Trump administration seeks greater control over NIH grantmaking, while Susan Collins objects to the Office of Management and Budget's involvement.Sat 04:05
Massachusetts General Hospital
teaching hospital in Boston, Massachusetts, United States
- Solid Biosciences received FDA approval for a gene therapy trial on July 9, 2025.Sun 14:18
- Jo Buyske received her medical degree and awards while completing general surgery residency at Massachusetts General Hospital.Sat 03:59
QUANTUM
Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 8GlobeNewswireQuantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in